Randomized Feasibility Study of S-1 for Adjuvant Chemotherapy in Completely-Resected Stage IA Non-Small-Cell Lung Cancer (SLCG 0701)

被引：0
|
作者：
Okumura, Norihito [1 ]
Soh, Junichi [2 ]
Nakata, Masao [3 ]
Nakamura, Hiroshige [4 ]
Fukuda, Minoru [5 ]
Kataoka, Masafumi [6 ]
Kajiwara, Shinsuke [7 ]
Sano, Yoshifumi [8 ]
Aoe, Motoi [9 ]
Kataoka, Kazuhiko [10 ]
Hotta, Katsuyuki [2 ]
Matsuo, Keitaro [11 ]
Toyooka, Shinichi [2 ]
Date, Hiroshi [12 ]
机构：
[1] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[4] Tottori Univ, Fac Med, Yonago, Tottori 683, Japan
[5] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[6] Okayama Saiseikai Gen Hosp, Okayama, Japan
[7] Uwajima City Hosp, Uwajima, Japan
[8] Ehime Univ Hosp, Touon, Japan
[9] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[10] Iwakuni Clin Ctr, Iwakuni, Japan
[11] Kyushu Univ, Fac Med Sci, Fukuoka 812, Japan
[12] Kyoto Univ, Grad Sch Med, Kyoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
adjuvant chemotherapy; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-032
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [41] A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
    Schmid-Bindert, Gerald
    Engel-Riedel, Walburga
    Reck, Martin
    Schuette, Wolfgang
    Stoehlmacher, Jan
    Fischer, Juergen R.
    Mazieres, Julien
    Chouaid, Christos
    Wolf, Martin
    Vinolas, Nuria
    Soldatenkova, Victoria
    Ripoche, Veronique
    Nguyen, Tuan
    Visseren-Grul, Carla
    LUNG CANCER, 2015, 90 (03) : 397 - 404
  • [42] A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Zheng Shi Ying
    Jiang Dong
    Li Hong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S518 - S518
  • [43] Adjuvant chemotherapy in completely resected non-small-cell lung cancer (vol 23, pg 3270, 2005)
    Pisters
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5851 - 5851
  • [44] Adjuvant chemotherapy in completely resected non-small-cell lung cancer (vol 23, pg 3270, 2005)
    Pisters
    Le Chevalier
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2238 - 2238
  • [45] Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: Have we made progress?
    Feld, R
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1045 - 1047
  • [46] Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Zhang, Q.
    Ke, L.
    Huang, S.
    Yang, Y.
    He, T.
    Sun, H.
    Wu, Z.
    Zhang, X.
    Lv, W.
    Hu, J.
    Ye, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S555 - S556
  • [47] Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer
    Hamada, C
    Ohta, M
    Nada, H
    Fujimura, S
    Kodama, K
    Imaizumi, M
    Nakanishi, Y
    Matsuoka, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 617S - 617S
  • [48] Is Advanced Age a Prognostic Factor for Adjuvant Chemotherapy in Completely Resected Non-Small-Cell Lung Cancer (NSCLC)?
    Batum, O.
    Anar, C.
    Ozdogan, Y.
    Ermin, S.
    Yilmaz, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN IN PATIENTS WITH COMPLETELY RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER
    FELD, R
    RUBINSTEIN, L
    THOMAS, PA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04): : 299 - 306
  • [50] Compliance with adjuvant chemotherapy for completely resected non-small cell lung cancer
    Lee, Hyun-Sung
    Kim, Moon Soo
    Lee, Jong Mog
    Kim, Heung Tae
    Zo, Jae Ill
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S480
12345